Human T Lymphotropic Virus Type I-II (HTLV)
Private HTLV I & II blood testing in London for £99, detecting one antibody marker linked with HTLV exposure, with results expected in around 5 days.
Turnaround time
5 business days
Biomarkers count
1
Book your test
Choose Service Type
Professional phlebotomist comes to you
+ £{{ home_visit_fee }}
Visit our clinic for your test
{{ clinic_visit_fee > 0 ? '+ £' + clinic_visit_fee : 'Free' }}
Home Visit Details
Home visits require at least 24 hours notice.
Select a clinic: Sorting by distance…
{{ clinicAddress(clinic) }}
{{ clinicAddress(selectedClinic) }}
Select a date
Select an hour
Available time slots: {{ timeSlots.length}}
Overview of the Human T Lymphotropic Virus Type I-II (HTLV) Test
The Human T Lymphotropic Virus Type I-II (HTLV) blood test detects antibodies produced following infection with Human T Lymphotropic Virus types I and II.
The test contains 1 biomarker: Human T Lymphotropic Virus Type I-II (HTLV).
HTLV is a retrovirus that infects T lymphocytes, a type of white blood cell involved in immune regulation.
HTLV-I is the more clinically significant type and is associated with a small number of serious long-term complications.
These include Adult T-cell Leukaemia/Lymphoma and a chronic neurological condition known as HTLV-associated myelopathy or tropical spastic paraparesis.
Importantly, most people infected with HTLV-I never develop these complications.
HTLV-II is closely related but has a less clearly defined association with disease.
HTLV can be transmitted through sexual contact, contaminated blood or needles, organ transplantation and from mother to child, particularly through prolonged breastfeeding.
Prevalence varies geographically, with higher rates in selected areas of Japan, the Caribbean, South America, sub-Saharan Africa and other regions.
The standard screening approach detects antibodies rather than the virus directly.
A reactive screening result usually requires confirmatory testing before an HTLV infection is regarded as established.
Antibodies generally remain detectable after infection, meaning this is not a test that distinguishes recent infection from infection acquired many years earlier.
The result should therefore be interpreted with exposure history, geographical background and any neurological or haematological findings.
What Does the Human T Lymphotropic Virus Type I-II (HTLV) Test Check?
The test assesses whether antibodies associated with infection by HTLV-I or HTLV-II are detectable in the blood. This test measures 1 biomarker.
Human T Lymphotropic Virus Type I-II (HTLV)
Detects antibodies associated with exposure to HTLV-I or HTLV-II and supports screening for infection, with confirmatory testing required for reactive results.
Who May Benefit From the Human T Lymphotropic Virus Type I-II (HTLV) Test?
HTLV testing may be useful where a recognised exposure risk, geographical background, partner status or unexplained compatible neurological or haematological condition raises concern about infection.
People with a sexual partner known to have HTLV - Sexual transmission can occur, making testing appropriate after recognised exposure.
People who have lived in or have close family links to an HTLV-endemic region - Infection prevalence differs substantially between geographic populations.
People with a history of blood exposure in settings where HTLV screening may not have been routine - Transfusion-related transmission has historically occurred.
People who have shared injecting equipment - Blood-to-blood exposure can transmit HTLV.
People undergoing investigation of unexplained myelopathy - HTLV-I is associated with HTLV-associated myelopathy/tropical spastic paraparesis.
People undergoing investigation of certain T-cell malignancies - HTLV-I is associated with Adult T-cell Leukaemia/Lymphoma.
People specifically advised to undergo HTLV screening - Testing may be requested for fertility treatment, transplantation, donation or other clinical pathways.
People with a previous reactive HTLV screening test - Repeat or confirmatory testing may be required before infection is established.
How to Prepare
There is no need to alter normal medication or diet before HTLV antibody testing.
A reactive screening result requires an appropriate confirmatory pathway before HTLV infection is considered confirmed.
Symptoms and Reasons to Consider the Human T Lymphotropic Virus Type I-II (HTLV) Test
Most people with HTLV infection have no symptoms, and complications may take many years to develop in the minority who become clinically affected.
No symptoms but a recognised exposure risk - HTLV can remain clinically silent for many years.
Progressive stiffness or weakness in the legs - HTLV-associated myelopathy can cause slowly progressive neurological impairment.
Changes in walking or balance with appropriate epidemiological risk - Chronic spinal-cord involvement can affect mobility.
Bladder symptoms occurring with progressive neurological changes - Urinary dysfunction can occur in HTLV-associated myelopathy.
Unexplained T-cell abnormalities or lymphoproliferative disease - HTLV-I testing can contribute to specialist haematological investigation.
A partner diagnosed with HTLV - Testing can establish whether infection has also occurred.
A previous reactive HTLV test - Confirmation is important before conclusions are drawn.
These symptoms are not specific to HTLV and can have many neurological, haematological or urological causes.
Progressive neurological weakness, substantial gait deterioration or suspected blood malignancy requires specialist assessment rather than reliance on an isolated screening result.
How to Book Your Human T Lymphotropic Virus Type I-II (HTLV) Test
The HTLV test can be booked privately through London Blood Tests for confidential retroviral antibody screening.
Choose the Human T Lymphotropic Virus Type I-II (HTLV)
Select the individual HTLV blood test online.
Select your sample collection option
Choose an in-clinic blood draw or professional home or hotel phlebotomy where appropriate.
Attend your appointment
A trained healthcare professional collects the required venous blood sample.
Laboratory analysis
Your serum is analysed for antibodies associated with HTLV-I and HTLV-II.
Receive your results securely
Your authorised result is delivered securely, with confirmatory testing or specialist review advised where appropriate.
When Will I Receive My Results?
The current expected turnaround for Human T Lymphotropic Virus Type I-II (HTLV) is approximately 5 days after the sample reaches the laboratory.
HTLV antibody testing is a specialist viral serology investigation.
The specimen undergoes antibody screening, laboratory quality-control procedures and result authorisation before reporting.
Turnaround begins when the sample enters the laboratory rather than necessarily from the exact time of blood collection.
If the initial screening assay is reactive, additional confirmatory testing may be required.
This can extend the overall time before a definitive result is available because a reactive screening test should not be treated as the final diagnosis.
Understanding Your Results
A negative screening result means HTLV-I/II antibodies were not detected at the assay threshold.
Where testing has occurred sufficiently long after potential exposure, this is reassuring.
Very recent exposure may require consideration of the window period and repeat testing according to specialist advice.
A reactive or positive screening result means antibodies that may be associated with HTLV have been detected.
Because screening assays can occasionally produce non-specific reactivity, confirmatory testing is normally required.
A confirmed positive result indicates HTLV infection but does not mean that the person will develop HTLV-associated disease.
Most people with confirmed HTLV-I remain asymptomatic throughout life.
Where infection is confirmed, clinical counselling can address transmission risk, partner testing and whether additional neurological or haematological assessment is appropriate.
Why Book With London Blood Tests?
London Blood Tests provides confidential private access to specialist HTLV antibody testing.
Tests for HTLV-I and HTLV-II exposure - Screens for antibodies associated with both major HTLV types.
Relevant to recognised exposure risks - Suitable after appropriate sexual or blood-related exposure.
Useful in selected neurological investigations - HTLV-I can be associated with chronic myelopathy.
Relevant to specialist haematology - HTLV-I is associated with Adult T-cell Leukaemia/Lymphoma.
Confidential private testing - Results are delivered securely.
Professional venous blood collection - Clinic and suitable mobile collection options are available.
Specialist laboratory analysis - Samples are processed through an appropriate virology pathway.
Clear pricing - The HTLV test costs £99.
Private Human T Lymphotropic Virus Type I-II (HTLV) Blood Test in London
London Blood Tests provides private HTLV-I and HTLV-II antibody testing in London for people requiring confidential screening or specialist investigation.
The test costs £99 and measures 1 biomarker.
Results are expected approximately 5 days after laboratory receipt.
A reactive screening result normally requires confirmation before an HTLV diagnosis is made.